These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 8324219

  • 1. Control of programmed cell death in normal and leukemic cells: new implications for therapy.
    Sachs L, Lotem J.
    Blood; 1993 Jul 01; 82(1):15-21. PubMed ID: 8324219
    [Abstract] [Full Text] [Related]

  • 2. Control of apoptosis in hematopoiesis and leukemia by cytokines, tumor suppressor and oncogenes.
    Lotem J, Sachs L.
    Leukemia; 1996 Jun 01; 10(6):925-31. PubMed ID: 8667646
    [Abstract] [Full Text] [Related]

  • 3. Granulocyte-macrophage colony-stimulating factor/interleukin-3 fusion protein (pIXY 321) enhances high-dose Ara-C-induced programmed cell death or apoptosis in human myeloid leukemia cells.
    Bhalla K, Tang C, Ibrado AM, Grant S, Tourkina E, Holladay C, Hughes M, Mahoney ME, Huang Y.
    Blood; 1992 Dec 01; 80(11):2883-90. PubMed ID: 1450413
    [Abstract] [Full Text] [Related]

  • 4. Differentiation primary response genes and proto-oncogenes as positive and negative regulators of terminal hematopoietic cell differentiation.
    Liebermann DA, Hoffman B.
    Stem Cells; 1994 Jul 01; 12(4):352-69. PubMed ID: 7951003
    [Abstract] [Full Text] [Related]

  • 5. The control of hematopoiesis and leukemia: from basic biology to the clinic.
    Sachs L.
    Proc Natl Acad Sci U S A; 1996 May 14; 93(10):4742-9. PubMed ID: 8643473
    [Abstract] [Full Text] [Related]

  • 6. Regulation of apoptosis induced by the retinoid N-(4-hydroxyphenyl) retinamide and effect of deregulated bcl-2.
    Delia D, Aiello A, Formelli F, Fontanella E, Costa A, Miyashita T, Reed JC, Pierotti MA.
    Blood; 1995 Jan 15; 85(2):359-67. PubMed ID: 7811993
    [Abstract] [Full Text] [Related]

  • 7. Interferon-gamma inhibits apoptosis induced by wild-type p53, cytotoxic anti-cancer agents and viability factor deprivation in myeloid cells.
    Lotem J, Sachs L.
    Leukemia; 1995 Apr 15; 9(4):685-92. PubMed ID: 7723404
    [Abstract] [Full Text] [Related]

  • 8. The novel primary response gene MyD118 and the proto-oncogenes myb, myc, and bcl-2 modulate transforming growth factor beta 1-induced apoptosis of myeloid leukemia cells.
    Selvakumaran M, Lin HK, Sjin RT, Reed JC, Liebermann DA, Hoffman B.
    Mol Cell Biol; 1994 Apr 15; 14(4):2352-60. PubMed ID: 8139540
    [Abstract] [Full Text] [Related]

  • 9. Functional aspects of apoptosis in hematopoiesis and consequences of failure.
    McKenna SL, Cotter TG.
    Adv Cancer Res; 1997 Apr 15; 71():121-64. PubMed ID: 9111865
    [Abstract] [Full Text] [Related]

  • 10. MCL1, a gene expressed in programmed myeloid cell differentiation, has sequence similarity to BCL2.
    Kozopas KM, Yang T, Buchan HL, Zhou P, Craig RW.
    Proc Natl Acad Sci U S A; 1993 Apr 15; 90(8):3516-20. PubMed ID: 7682708
    [Abstract] [Full Text] [Related]

  • 11. Effect of hemopoietic growth factors G-CSF and pIXY 321 on the activity of high dose Ara-C in human myeloid leukemia cells.
    Bhalla K, Tourkina E, Huang Y, Tang C, Mahoney ME, Ibrado AM.
    Leuk Lymphoma; 1993 Apr 15; 10 Suppl():123-31. PubMed ID: 7683227
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Dissection of the genetic programs of p53-mediated G1 growth arrest and apoptosis: blocking p53-induced apoptosis unmasks G1 arrest.
    Guillouf C, Graña X, Selvakumaran M, De Luca A, Giordano A, Hoffman B, Liebermann DA.
    Blood; 1995 May 15; 85(10):2691-8. PubMed ID: 7742528
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Differential effects of TGF-beta 1 on normal and leukemic human hematopoietic cell proliferation.
    Murohashi I, Endho K, Nishida S, Yoshida S, Jinnai I, Bessho M, Hirashima K.
    Exp Hematol; 1995 Aug 15; 23(9):970-7. PubMed ID: 7543418
    [Abstract] [Full Text] [Related]

  • 17. c-Myc sensitization to oxygen deprivation-induced cell death is dependent on Bax/Bak, but is independent of p53 and hypoxia-inducible factor-1.
    Brunelle JK, Santore MT, Budinger GR, Tang Y, Barrett TA, Zong WX, Kandel E, Keith B, Simon MC, Thompson CB, Hay N, Chandel NS.
    J Biol Chem; 2004 Feb 06; 279(6):4305-12. PubMed ID: 14627695
    [Abstract] [Full Text] [Related]

  • 18. Suppression of apoptosis in a cytotoxic T-cell line by interleukin 2-mediated gene transcription and deregulated expression of the protooncogene bcl-2.
    Deng G, Podack ER.
    Proc Natl Acad Sci U S A; 1993 Mar 15; 90(6):2189-93. PubMed ID: 8460122
    [Abstract] [Full Text] [Related]

  • 19. Flt3 ligand stimulates proliferation and inhibits apoptosis of acute myeloid leukemia cells: regulation of Bcl-2 and Bax.
    Lisovsky M, Estrov Z, Zhang X, Consoli U, Sanchez-Williams G, Snell V, Munker R, Goodacre A, Savchenko V, Andreeff M.
    Blood; 1996 Nov 15; 88(10):3987-97. PubMed ID: 8916965
    [Abstract] [Full Text] [Related]

  • 20. Selective induction of apoptosis in myeloid leukemic cell lines by monoacetone glucose-3 butyrate.
    Calabresse C, Venturini L, Ronco G, Villa P, Degos L, Belpomme D, Chomienne C.
    Biochem Biophys Res Commun; 1994 May 30; 201(1):266-83. PubMed ID: 8198584
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.